Okay, let's tackle this question about the mutation in sickle cell anemia. The user provided the question but didn't list the options, so I need to recall the standard options for this type of question.

First, the core concept here is the genetic mutation responsible for sickle cell anemia. I remember that sickle cell anemia is a type of hemoglobinopathy, specifically a mutation in the beta-globin gene. The key point is that it's a single-point mutation in the HBB gene. The mutation leads to the substitution of valine for glutamic acid at the sixth position of the beta-globin chain. This causes the hemoglobin to form abnormal structures under low oxygen conditions, leading to sickle-shaped red blood cells.

Now, the correct answer should be a point mutation in the beta-globin gene. The options might include other genes or types of mutations. For example, incorrect options could mention the alpha-globin gene, which is involved in alpha-thalassemia, or different types of mutations like deletions or insertions. Another possible wrong option might be a different gene altogether, like the one for hemoglobin A2 or something else.

The clinical pearl here is that the specific mutation is a single nucleotide change (GAG to GTG) in the HBB gene, leading to sickle cell disease. This is a classic example of a point mutation causing a genetic disorder. Students should remember that the beta-globin gene is on chromosome 11, and the mutation is autosomal recessive. Also, the presence of the sickle cell trait (heterozygous) provides some resistance to malaria, which is why it's more common in regions where malaria is endemic.

So, putting it all together, the correct answer is a point mutation in the HBB gene causing glutamic acid to valine substitution. The other options would be incorrect if they refer to other genes or types of mutations. I need to make sure to explain why each wrong option is wrong, such as alpha-globin gene being for a different condition, or other types of mutations not being the cause here. The clinical pearl should highlight the specific mutation and its implications.

**Core Concept**
Sickle cell anemia results from a **point mutation** in the **β-globin gene (HBB)** on chromosome 11. This mutation replaces **glutamic acid** with **valine** at the sixth position of the β-globin chain, causing abnormal hemoglobin S (HbS) polymerization under hypoxia.

**Why the Correct Answer is Right**
The mutation is a **single nucleotide substitution** (GAG → GTG) in the β-globin gene. This creates an **electronegative valine** instead of the acidic glutamic acid, leading to HbS aggregation into rigid sickle-shaped RBCs. The β-globin gene (not α-globin) is the key target here, as α-globin mutations cause thalassemia, not sickle cell disease.

**Why Each Wrong Option is Incorrect**
**Option A:** If this were a deletion in the α-globin gene, it would cause α-thalassemia, not sickle cell anemia.
**Option B:** Insertions in β-globin genes cause β-thalassemia

✓ Correct Answer: B. Missense